Psoriasis
The AJMC® Psoriasis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin disease, which tends to go through cycles where it flares and goes into remission.
Latest News
Icotrokinra Shows Clear Skin in 75% of Adolescents With Plaque Psoriasis in Phase 3 Trial
Women Have Lower Drug Survival With Biologics for Psoriasis, Including IL-17 and IL-23 Inhibitors
Tildrakizumab Effective Up to Nearly 3 Years Regardless of BSA Affected, Obesity
Biologics Linked to Lower Infection Risk in Older Adults With Psoriatic Disease
A Personalized Approach to Disease Management in Psoriasis
A panel of experts discuss their personalized approaches to treating patients with psoriasis and comorbidities such as metabolic syndrome.
The Future of Oral Therapy for Psoriasis Management
Zasocitinib’s Potential as an Oral Treatment for Psoriasis
Dr Chesahna Kindred: Diverse Clinical Trials Are a Long-Game to Close the Health Equity Gaps
Dr Chesahna Kindred Addresses Diversity Barriers in Clinical Trials
Dr Chesahna Kindred Discusses the Strengths of Diversity in Psoriasis Clinical Trials
Dr Joseph Zabinski Discusses Challenges in Identifying Patients With GPP
Dr Joseph Zabinski Discusses Using Artificial Intelligence to Identify Patients With GPP
JNJ-2113 Shows Promising Response Rates Compared With Competitor Oral Therapies for Psoriasis
The Importance of Cultural, Social, and Clinical Diversity in Treating Plaque Psoriasis
Dr Mona Shahriari Talks Unique Challenges in Treating Psoriasis in Patients With Skin of Color
More News
